Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

ClinicalTrials.gov ID: NCT07202546

Public ClinicalTrials.gov record NCT07202546. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b Randomized, Open-Label Active Controlled Study Evaluating the Safety and Efficacy of Oral VH4524184 Coadministered With Emtricitabine and Tenofovir Alafenamide in Treatment Naive Viremic Persons With HIV-1 (INNOVATE Study)

Study identification

NCT ID
NCT07202546
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
ViiV Healthcare
Industry
Enrollment
150 participants

Conditions and interventions

Conditions

Interventions

  • VH4524184 Drug
  • Emtricitabine (FTC) and tenofovir alafenamide (TAF) Fixed Dose Combination (FDC) tablets Drug
  • Dolutegravir / Lamivudine (DTG/3TC) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 10, 2026
Primary completion
Jul 25, 2027
Completion
Jul 23, 2028
Last update posted
May 7, 2026

2026 – 2028

United States locations

U.S. sites
31
U.S. states
14
U.S. cities
30
Facility City State ZIP Site status
GSK Investigational Site Bakersfield California 93301 Recruiting
GSK Investigational Site Palm Springs California 92262 Recruiting
GSK Investigational Site West Hollywood California 90046 Recruiting
GSK Investigational Site Aurora Colorado 80045 Recruiting
GSK Investigational Site New Haven Connecticut 06501 Recruiting
GSK Investigational Site Ft. Pierce Florida 34982 Recruiting
GSK Investigational Site Hollywood Florida 33021 Recruiting
GSK Investigational Site Miami Florida 33136 Recruiting
GSK Investigational Site Miami Gardens Florida 33055 Recruiting
GSK Investigational Site Oakland Park Florida 33334 Recruiting
GSK Investigational Site Orlando Florida 32803 Recruiting
GSK Investigational Site West Palm Beach Florida 33409 Recruiting
GSK Investigational Site Atlanta Georgia 30308 Recruiting
GSK Investigational Site Macon Georgia 31201 Recruiting
GSK Investigational Site Louisville Kentucky 40202 Recruiting
GSK Investigational Site Columbia Missouri 65212 Recruiting
GSK Investigational Site Kansas City Missouri 64111 Recruiting
GSK Investigational Site Omaha Nebraska 68106 Recruiting
GSK Investigational Site Newark New Jersey 07102 Recruiting
GSK Investigational Site Albany New York 12208 Recruiting
GSK Investigational Site Manhasset New York 11030 Recruiting
GSK Investigational Site Charlotte North Carolina 28204 Recruiting
GSK Investigational Site Greensboro North Carolina 27401 Recruiting
GSK Investigational Site Wilmington North Carolina 28401 Recruiting
GSK Investigational Site Cincinnati Ohio 45267 Recruiting
GSK Investigational Site Bellaire Texas 77401 Recruiting
GSK Investigational Site Dallas Texas 75246 Recruiting
GSK Investigational Site Houston Texas 77025 Recruiting
GSK Investigational Site Houston Texas 77030 Recruiting
GSK Investigational Site Longview Texas 75605 Recruiting
GSK Investigational Site Seattle Washington 98104 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 81 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07202546, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07202546 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →